• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Hikal Ltd.
    15 Jul 2024
    257.45
    -0.94%
    MRPL, Hikal among top picks by Jigar S Patel of Anand Rathi for July 15
    Business Standard
    Between March 2023 and June 2024, Hikal has been consolidating within the approximate range of Rs 260-320
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 92 to 104 in Jun 2025 qtr.
    logo
    AstraZeneca Pharma India Ltd.
    14 Jul 2024
    Show Cause Notice
    9003.50
    -0.75%
    Tamil Nadu turns latest hotspot for GCCs; adds 50,000 jobs in three years
    Business Standard
    Not just AstraZeneca, but Pfizer and Roche have also set up their centres in the state
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.
    logo
    Cipla Ltd.
    14 Jul 2024
    1574.60
    0.88%
    Cipla navigates change, building on its crusader-in-crisis' legacy
    Business Line
    Product pipeline: The plan now is to increase innovative revenue' through partnerships and innovation
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
    logo
    Alembic Pharmaceuticals Ltd.
    12 Jul 2024, 05:29PM
    946.50
    -0.07%
    Alembic Pharma Gets Tentative US FDA Nod For Pulmonary Arterial Hypertension Treatment
    Alembic Pharma Gets Tentative US FDA Nod For Pulmonary Arterial Hypertension Treatment
    NDTV Profit
    Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalisation.
    Copy LinkShare onShare on Share on Share on
    Alembic Pharmaceutic.. has an average target of 1001.00 from 4 brokers.
    logo
    Alivus Life Sciences Ltd.
    11 Jul 2024, 08:41PM
    936.90
    -0.83%
    Glenmark Life Sciences dips on Glenmark Pharma's plan to exit
    Business Line
    Development comes about 10 months after Glenmark Pharma sold 75 percent stake in GLS to Nirma
    Copy LinkShare onShare on Share on Share on
    Alivus Life Sciences Ltd. has lost -28.26% in the last 1 Year
    logo
    Lupin Ltd.
    11 Jul 2024, 01:07PM
    2043.40
    2.79%
    Lupin - Launches Critical For Sustenance Of Turnaround: ICICI Securities
    Lupin - Launches Critical For Sustenance Of Turnaround: ICICI Securities
    NDTV Profit
    US growth contingent on launches and regulatory compliance; India formulation business to grow at a steady pace
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    logo
    Glenmark Pharmaceuticals Ltd.
    11 Jul 2024, 11:26AM
    Dividend
    2132.50
    0.23%
    Glenmark Pharma Hits All-Time High On Plan To Exit Glenmark Life
    Glenmark Pharma Hits All-Time High On Plan To Exit Glenmark Life
    NDTV Profit
    Glenmark Pharma's stock rose 1% in early trade to Rs 1,393 apiece on the NSE.
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuticals Ltd. has gained 49.93% in the last 6 Months
    Glenmark Pharma shares slide on plans to divest stake in Glenmark Life
    Business Standard | 11 Jul 2024
    logo
    Mankind Pharma Ltd.
    10 Jul 2024
    2579.60
    -0.75%
    Mankind Pharma Shares Rise As Capital Group Affiliate Offloads Nearly 1% Stake
    Mankind Pharma Shares Rise As Capital Group Affiliate Offloads Nearly 1% Stake
    NDTV Profit
    Hema CIPEF Ltd. sold 0.9% stake in Mankind Pharma via block sale, according to terms of the deal obtained by Bloomberg News.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.
    Mankind Pharma rallies 5% after 3.7 mn shares change hands via block deal
    Business Standard | 10 Jul 2024
    logo
    Emcure Pharmaceuticals Ltd.
    10 Jul 2024
    1348.90
    -2.02%
    Emcure Pharma listing: Stock makes solid debut on NSE, BSE with 31% premium
    Business Standard
    Emcure Pharmaceuticals listing: Stock made a strong market debut as they got listed at Rs 1,325, a 31 per cent premium over the issue price of Rs 1,008 on the NSE and BSE today
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd. is trading below its 30 day SMA of 1413.4
    Stocks to watch, July 10: Angel One, Emcure Pharma, Mankind Pharma, MM
    Business Standard | 10 Jul 2024
    logo
    Alembic Pharmaceuticals Ltd.
    09 Jul 2024
    946.50
    -0.07%
    Alembic Pharma receives USFDA nod for Bromfenac Ophthalmic Solution
    Business Standard
    The drug is expected to be manufactured in Alembic's manufacturing facilities in Gujarat, according to sources close to the company
    Copy LinkShare onShare on Share on Share on
    Alembic Pharmaceutic.. has an average target of 1001.00 from 4 brokers.
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd